Increased expression of inhibitor of apoptosis proteins in atherosclerotic plaques of symptomatic patients with carotid stenosis

Experimental and Molecular Pathology

Volumn 83, Issue 1, 2007, Pages 11-16

  Moran, Edward P ^a   Agrawal, Devendra K ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Atherosclerosis; Carotid endarterectomy; Carotid plaque; Inhibitors of apoptosis; PCNA; Vascular smooth muscle cell

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE 3; CELLULAR INHIBITOR OF APOPTOSIS PROTEIN 2; CYCLINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYOSIN HEAVY CHAIN; PROTEIN; SURVIVIN; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; DEFENSE MECHANISM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; PROTEIN EXPRESSION; STIMULUS;

AGED; ATHEROSCLEROSIS; CAROTID STENOSIS; CELL SHAPE; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION MEDIATORS; INHIBITOR OF APOPTOSIS PROTEINS; MALE; MYOCYTES, SMOOTH MUSCLE;

INTRACISTERNAL A-PARTICLES;

EID: 34249322866     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2006.09.006     Document Type: Article

References (27)

1. Abebe W., Cavallari N., and Agrawal D.K. Functional and morphological assessment of rat aorta stored in University of Wisconsin and Eurocollins solutions. Transplantation 56 (1993) 808-816
2. Allen R.T., Krueger K.D., Dhume A., and Agrawal D.K. Sustained Akt/PKB activation and transient attenuation of c-Jun N-terminal kinase in the inhibition of apoptosis by IGF-1 in vascular smooth muscle cells. Apoptosis 10 (2005) 525-535
3. Allen R.T., Krueger K.D., Hunter W.J., and Agrawal D.K. Evidence that IGF-1 requires PKC-ε, PI3-kinase and MAP kinase pathways to protect human and rat vascular smooth muscle cells from apoptosis. Immunol. Cell Biol. 83 (2005) 651-667
4. Ambrosini G., Adida C., and Altieri D.C. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat. Med. 8 (1997) 917-921
5. Artese L., Ucchino S., Piattelli A., Piccirilli M., Perrotti V., Mezzetti A., and Cipollone F. Factors associated with apoptosis in symptomatic and asymptomatic carotid atherosclerotic plaques. Int. J. Immunopathol. Pharmacol. 4 (2005) 645-653
6. Balaram S.K., Agrawal D.K., Allen R.T., Kuszynski C.A., and Edwards J.D. Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. J. Vasc. Surg. 5 (1997) 866-876
7. Biller J., Feinberg W.M., Castaldo J.E., Whittemore A.D., Harbaugh R.E., Dempsey R.J., Caplan L.R., Kresowik T.F., Matchar D.B., Toole J.F., Easton J.D., Adams Jr. H.P., Brass L.M., Hobson II R.W., Brott T.G., and Sternau L. Guidelines for carotid endarterectomy: a statement for healthcare professionals from a Special Writing Group of the Stroke Council, American Heart Association. Circulation 97 (1998) 501-509 Review
8. Chaudhari B.R., Murphy R.F., and Agrawal D.K. Following the TRAIL to apoptosis. Immunol. Res. 35 3 (2006) 1-14
9. Cho A., Mitchell L., Koopmans D., and Langille B.L. Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ. Res. 81 (1997) 328-337
10. de Winther M.P., Kanters E., Kraal G., and Hofker M.H. Nuclear factor kappaB signaling in atherogenesis. Arterioscler., Thromb., Vasc. Biol. 5 (2005) 904-914
11. Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 388 6639 (1997) 300-304
12. Dhume, A.S., 2002. Carotid atherosclerosis: Why some patients are symptomatic and others not? Ph.D. (Biomedical Sciences) dissertation. Creighton University, Omaha, Nebraska, USA.
13. Dhume A.S., and Agrawal D.K. Inability of vascular smooth muscle cells to proceed beyond S phase of cell cycle, and increased apoptosis in symptomatic carotid artery disease. J. Vasc. Surg. 38 (2003) 155-161
14. Dhume A.S., Soundararajan K., Hunter III W.J., and Agrawal D.K. Comparison of vascular smooth muscle cell apoptosis and fibrous cap morphology in symptomatic and asymptomatic carotid artery disease. Ann. Vasc. Surg. 17 (2003) 1-8
15. Gordon D., Reidy M.A., Benditt E.P., and Schwartz S.M. Cell proliferation in human coronary arteries. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 4600-4604
16. Hutter R., Valdiviezo C., Sauter B.V., Savontaus M., Chereshnev I., Carrick F.E., Bauriedel G., Luderitz B., Fallon J.T., Fuster V., and Badimon J.J. Caspase-3 and tissue factor expression in lipid-rich plaque macrophages: evidence for apoptosis as link between inflammation and atherothrombosis. Circulation 109 (2004) 2001-2008
17. Jia G., Cheng G., and Agrawal D.K. Differential effects of insulin-like growth factor-1 and atheroma-associated cytokines on cell proliferation and apoptosis in plaque smooth muscle cells of symptomatic and asymptomatic patients with carotid stenosis. Immunol. Cell Biol. 84 (2006) 422-429
18. Li H., Telemaque S., Miller R.E., and Marsh J.D. High glucose inhibits apoptosis induced by serum deprivation in vascular smooth muscle cells via upregulation of Bcl-2 and Bcl-xl. Diabetes 54 (2005) 540-545
19. Louridas G., and Junaid A. Management of carotid artery stenosis. Update for family physicians. Can. Fam. Physician. 5 (2005) 1984-1989
20. Mitra A.K., Dhume A.S., and Agrawal D.K. Vulnerable plaques: ticking of the time bomb. Can. J. Physiol. Pharmacol. 82 (2004) 860-871
21. Morioka M., Hamada J., Hashiguchi A., Hasegawa Y., Todaka T., Yano S., Kai Y., Miura M., Fujioka S., and Ushio Y. Contribution of angiotensin-converting enzyme and angiotensin II to ischemic stroke: their role in the formation of stable and unstable carotid atherosclerotic plaques. Surg. Neurol. 62 (2004) 292-301 discussion 301-303
22. Rose A., Froment P., Perrot V., Quon M.J., LeRoith D., and Dupont J. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary alphaT3 cells by protein kinase Calpha-mediated negative regulation of Akt. J. Biol. Chem. 279 (2004) 52500-52516
23. Roy N., Deveraux Q.L., Takahashi R., Salvesen G.S., and Reed J.C. The c-IAP-1 and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J. 116 (1997) 6914-6925
24. Simosa H.F., Wang G., Sui X., Peterson T., Narra V., Altieri D.C., and Conte M.S. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J. Vasc. Surg. 41 (2005) 682-690
25. von Wnuck Lipinski K., Keul P., Lucke S., Heusch G., Wohlschlaeger J., Baba H.A., and Levkau B. Degraded collagen induces calpain-mediated apoptosis and destruction of the X-chromosome-linked inhibitor of apoptosis (xIAP) in human vascular smooth muscle cells. Cardiovasc. Res. 69 (2006) 697-705
26. Yadav J.S., Wholey M.H., Kuntz R.E., Fayad P., Katzen B.T., Mishkel G.J., Bajwa T.K., Whitlow P., Strickman N.E., Jaff M.R., Popma J.J., Snead D.B., Cutlip D.E., Firth B.G., and Ouriel K. Stenting and angioplasty with protection in patients at high risk for endarterectomy investigators. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N. Engl. J. Med. 351 (2004) 1493-1501
27. In: Warlow C.P., Dennis M.S., van Gijn J., Sandrock P.A., Bamford J.M., and Wardlaw J. (Eds). Stroke: a practical guide to management (2001), Blackwell Science, Oxford, Eng. 223-300